Marchex Reports Q4 Results, Projects 2026 Growth, and Provides Key Update on Archenia Acquisition

summarizeSummary

Marchex reported a decline in Q4 and full-year 2025 revenue and increased losses, but provided strong 2026 guidance projecting a return to profitability and growth, alongside a material update on its proposed acquisition of Archenia, Inc., which is expected to significantly boost combined revenue and EBITDA.

check_boxKey Events

• Q4 and Full Year 2025 Financial Results

  Marchex reported GAAP revenue of $10.8 million for Q4 2025 (down from $11.9 million in Q4 2024) and $45.4 million for full year 2025 (down from $48.1 million in 2024). Net loss increased to $2.3 million in Q4 2025 and $5.2 million for the full year 2025.

• Positive 2026 Financial Outlook

  The company anticipates Q1 2026 revenue to be at Q4 2025 levels, with Adjusted EBITDA of $500,000 or more. For Q2 2026, revenue is expected to increase sequentially, with Adjusted EBITDA potentially exceeding $1 million. Marchex projects sequential quarterly revenue increases throughout 2026, aiming for a 10% run rate growth from 2025 year-end levels and Adjusted EBITDA margins of 10% or more.

• Material Update on Archenia Acquisition

  Marchex provided an update on its Agreement in Principle to acquire Archenia, Inc., anticipating a closing in June 2026, subject to disinterested stockholder approval. Archenia estimates over $17 million in revenue and positive Adjusted EBITDA for 2025. The combined company is projected to achieve approximately $60 million in annualized revenue with 15-20% growth and 10%+ Adjusted EBITDA margins, significantly expanding Marchex's market and capabilities.

auto_awesomeAnalysis

This filing presents a mixed financial picture for Marchex, with a decline in Q4 and full-year 2025 revenue and increased net losses. However, the forward-looking guidance is significantly positive, projecting a return to positive Adjusted EBITDA in Q1 2026 and sequential revenue growth throughout the year, aiming for a 10% run rate increase from 2025 levels. Crucially, the update on the proposed acquisition of Archenia, Inc. is highly material. Archenia's estimated 2025 revenue of over $17 million and positive Adjusted EBITDA would be substantially accretive to Marchex, potentially boosting the combined company's annualized revenue to approximately $60 million with 15-20% growth and 10%+ Adjusted EBITDA margins. This acquisition, if approved by disinterested stockholders and closed by June 2026, represents a significant strategic pivot and growth catalyst for Marchex, transforming its financial profile and market position.